GGrantIndex
← Leaderboards

Methodist Hospital Research Institute

Houston, TX

Compare ↔
$390,645,992
Total funding
346
Grants

Funding over time

peak $56.2M · FY2005–25
$100M$75M$50M$25M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$389,432,561 · 344
AHRQ$1,213,431 · 2

By mechanism

R01$263,969,496 · 173
U54$38,035,788 · 40
U01$24,593,648 · 10
R21$16,828,418 · 44
R56$7,881,660 · 17
P01$7,195,907 · 5

Investigators at Methodist Hospital Research Institute

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Dipan J. Shah$2,960,1391 gr2Francisco Altamirano$2,811,4572 gr3Dimitry Sayenko$2,544,3621 gr4Masayuki Nigo$2,398,6391 gr5Li Lai$1,615,0002 gr6Guangyu Wang$1,591,7082 gr7Trisha Roy$1,453,5511 gr8Alireza Faridar$1,227,3612 gr

Emerging Leaders

6–10 yrs in

1Kaifu Chen$6,629,6356 gr2Qi Cao$5,501,0095 gr3Wenhao Chen$2,641,7503 gr4Robert Conrad Krencik$2,427,3313 gr5Daniel Louis Kiss$2,250,0661 gr6Christoforos Thomas$2,239,5302 gr7Yi-Lan Weng$2,026,8611 gr8Hong Zhao$1,310,7041 gr

All-Time

Most funded here, all years

1Qing Yi$19,735,74914 gr2Xian Chang Li$17,078,69410 gr3Shu-Hsia Chen$16,255,14310 gr4Stephen Tc Wong$15,559,97513 gr5Dan Theodorescu$14,378,2477 gr6Alessandro Grattoni$14,325,4358 gr7Cesar Augusto Arias$12,392,2748 gr8Xiaobo Zhou$10,475,8329 gr

Largest grants

Age-related TDP-43 neuropathology: using disease-driving mechanisms to guide classification$3,179,031
RF1 · FY2020 · NS
Optimal Selective Thyroid Hormone Analogs for Metabolic Syndrome$2,921,456
RC4 · FY2010 · DK
Regulation of innate immunity by self-adjuvated MRNA vaccines$2,710,680
R01 · FY2025 · AI
Dynamics of Colonization and Infection by Multidrug-resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)$2,411,532
P01 · FY2022 · AI
Dynamics of Colonization and Infection by Multidrug-resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)$2,406,527
P01 · FY2024 · AI
Dynamics of Colonization and Infection by Multidrug-resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)$2,377,848
P01 · FY2025 · AI
Center for Systematic Modeling of Cancer Development$2,296,450
U54 · FY2010 · CA
Center for Transport Oncophysics$2,157,001
U54 · FY2011 · CA
Center for Transport Oncophysics$2,151,336
U54 · FY2012 · CA
Center for Systematic Modeling of Cancer Development$2,129,742
U54 · FY2011 · CA
Center for Systematic Modeling of Cancer Development$2,029,886
U54 · FY2013 · CA
Defining the altered FUS-PARP-1-DNA Ligase III axis and its implications to nuclear and mitochondrial genome damage response in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)$2,018,750
RF1 · FY2020 · NS
Center for Transport Oncophysics$2,017,064
U54 · FY2010 · CA
Center for Systematic Modeling of Cancer Development$2,016,673
U54 · FY2012 · CA
Center for Immunotherapeutic Transport Oncophysics$1,990,957
U54 · FY2016 · CA
Center for Immunotherapeutic Transport Oncophysics$1,865,321
U54 · FY2018 · CA
Center for Immunotherapeutic Transport Oncophysics$1,845,151
U54 · FY2017 · CA
Center for Systematic Modeling of Cancer Development$1,829,534
U54 · FY2014 · CA
Ultra-long Acting Transcutaneously Refillable Islatravir Nanofluidic Implant for HIV Pre-Exposure$1,801,942
R01 · FY2025 · AI
Center for Immunotherapeutic Transport Oncophysics$1,797,348
U54 · FY2020 · CA